NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT02892123 2024-11-27Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersJazz PharmaceuticalsPhase 1 Completed279 enrolled
NCT04943627 2022-10-05Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)Agenus Inc.Phase 3 Withdrawn